1. Home
  2. RVMD vs CARR Comparison

RVMD vs CARR Comparison

Compare RVMD & CARR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Revolution Medicines Inc.

RVMD

Revolution Medicines Inc.

SELL

Current Price

$183.99

Market Cap

40.3B

Sector

Health Care

ML Signal

SELL

Logo Carrier Global Corporation

CARR

Carrier Global Corporation

SELL

Current Price

$53.26

Market Cap

45.3B

Sector

Industrials

ML Signal

SELL

Company Overview

Basic Information
Metric
RVMD
CARR
Founded
2014
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
40.3B
45.3B
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
RVMD
CARR
Price
$183.99
$53.26
Analyst Decision
Strong Buy
Buy
Analyst Count
25
26
Target Price
★ $258.84
$68.79
AVG Volume (30 Days)
1.9M
★ 5.7M
Earning Date
11-04-2026
10-29-2026
Dividend Yield
N/A
★ 1.73%
EPS Growth
★ N/A
N/A
EPS
N/A
★ N/A
Revenue
N/A
★ $21,747,000,000.00
Revenue This Year
N/A
$9.17
Revenue Next Year
$526.64
$6.19
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$58.91
$50.24
52 Week High
$224.31
$76.76

Technical Indicators

Market Signals
Indicator
RVMD
CARR
Relative Strength Index (RSI) 56.58 48.85
Support Level $198.91 $53.91
Resistance Level $207.50 $57.16
Average True Range (ATR) 8.24 1.61
MACD 1.42 0.01
Stochastic Oscillator 86.26 54.31

Price Performance

Historical Comparison
RVMD
CARR

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.

About CARR Carrier Global Corporation

Carrier Global, spun out of United Technologies in 2020, manufactures and services commercial and residential HVAC systems and transportation refrigeration solutions under its flagship Carrier brand, as well as Bryant, Payne, Heil, and others across various price points. In 2024, Carrier acquired Viessmann Climate Solutions to expand its footprint in Europe with heat pumps, boilers, and solar PV equipment. Proceeds from the sale of Carrier's fire and security (Honeywell) and commercial refrigeration (Haier) businesses reduced debt and focused the company on global HVAC and refrigeration solutions. Carrier generates 75% of sales from equipment and 25% from parts and services. The company derives 50% of revenue from the US, 30% from Europe, and 20% from the Asia-Pacific region.

Share on Social Networks: